Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Anti-angiogenic Drug Combination
Mezzacappa C. Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Anti-angiogenic Drug Combination. Gastroenterology 2023, 166: 350. PMID: 37683705, DOI: 10.1053/j.gastro.2023.09.003.Commentaries, Editorials and LettersNew immune checkpointsUnresectable hepatocellular carcinomaImmune checkpointsHepatocellular carcinomaDrug combinationsCarcinoma